NCT01889745Temporarily Not Available不适用
A Phase I Clinical Study, Randomized, Single-blind,Placebo-controlled, Multiple Doses, Dose Escalation Study fo the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Temporarily Not Available
- 试验地点
- 1
研究概览
简要总结
This study is designed to multiple dose and dose escalation study
详细描述
A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Single Dose Escalation Study of the Safety, Tolerabiluty, and Pharmacokinetics of HX-1171 in Healthy Male Subjects
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 20 Years 至 40 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Adult males aged 20 to 40 years at screening.
- •Be able to comply with the requirement of the study. Subject must provide written informed consent prior to study participation.
排除标准
- •History or presence of liver, kidney, or nervous system disease, respiratory disorders, endocrinological disorders, hemato-oncologic, cardiovascular or psychiatric or gastrointestinal disorders.
- •History of known hypersensitivity to drugs including HX-1171.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid ArthritisSystemic Lupus ErythematosusRheumatoid ArthritisNCT03334851Pfizer74
已完成
1 期
A Phase 1, Randomized, Placebo-controlled, Single & Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Healthy Chinese VolunteersHealthyNCT02750553Jiangsu HengRui Medicine Co., Ltd.51
已完成
1 期
Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy VolunteersAllergic Rhinitis AsthmaNCT04161547CSPC ZhongQi Pharmaceutical Technology Co., Ltd.40
终止
1 期
Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy VolunteersHealthy VolunteersNCT02063594Marval Pharma Ltd.20
已完成
1 期
Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African AdultsPrevention of Malaria Transmission and Clinical MalariaNCT06507605Serum Institute of India Pvt. Ltd.240